Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2101 AL 2115

Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease

Cohen S, Cummings J, Knox S, Potashman M, Harrison J.

J Prev Alzheimers Dis. 2022;9(3):507-522. doi: 10.14283/jpad.2022.41.

The promise of music therapy for Alzheimer's disease: A review

Matziorinis AM, Koelsch S.

Ann N Y Acad Sci. 2022 Oct;1516(1):11-17. doi: 10.1111/nyas.14864. Epub 2022 Jul 18.

Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study

Cuberas-Borrós G, Roca I, Castell-Conesa J, Núñez L, Boada M, López OL, Grifols C, Barceló M, Pareto D, Páez A.

Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4589-4600. doi: 10.1007/s00259-022-05915-5. Epub 2022 Jul 22.

Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases

Custodia A, Romaus-Sanjurjo D, Aramburu-Núñez M, Álvarez-Rafael D, Vázquez-Vázquez L, Camino-Castiñeiras J, Leira Y, Pías-Peleteiro JM, Aldrey JM, Sobrino T, Ouro A.

Int J Mol Sci. 2022 Jul 22;23(15):8082. doi: 10.3390/ijms23158082.

Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments

Hoang K, Watt H, Golemme M, Perry RJ, Ritchie C, Wilson D, Pickett J, Fox C, Howard R, Malhotra PA.

Trials. 2022 Aug 1;23(1):623. doi: 10.1186/s13063-022-06190-3.

A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia

Yang Q, Liu J, Huang KL, Wang GY, Wang MY, Tan AH, Ran SM.

Medicine (Baltimore). 2022 Aug 5;101(31):e29307. doi: 10.1097/MD.0000000000029307.

Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment

Gomes P, Tzouanou F, Skolariki K, Vamvaka-Iakovou A, Noguera-Ortiz C, Tsirtsaki K, Waites CL, Vlamos P, Sousa N, Costa-Silva B, Kapogiannis D, Sotiropoulos I.

Exp Neurol. 2022 Dec;358:114183. doi: 10.1016/j.expneurol.2022.114183. Epub 2022 Aug 8.

New Possibilities in the Therapeutic Approach to Alzheimer's Disease

Doroszkiewicz J, Mroczko B.

Int J Mol Sci. 2022 Aug 10;23(16):8902. doi: 10.3390/ijms23168902.

Opportunities and challenges in delivering biologics for Alzheimer's disease by low-intensity ultrasound

Chen L, Cruz E, Oikari LE, Padmanabhan P, Song J, Götz J.

Adv Drug Deliv Rev. 2022 Oct;189:114517. doi: 10.1016/j.addr.2022.114517. Epub 2022 Aug 25.

Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-β-Amyloid Immunotherapy: A Meta-analysis

Jeong SY, Suh CH, Shim WH, Lim JS, Lee JH, Kim SJ.

Neurology. 2022 Nov 8;99(19):e2092-e2101. doi: 10.1212/WNL.0000000000201019. Epub 2022 Aug 29.

A Pilot Study of Whole-Brain Low-Intensity Pulsed Ultrasound Therapy for Early Stage of Alzheimer's Disease (LIPUS-AD): A Randomized, Double-Blind, Placebo-Controlled Trial

Shimokawa H, Shindo T, Ishiki A, Tomita N, Ichijyo S, Watanabe T, Nakata T, Eguchi K, Kikuchi Y, Shiroto T, Takahashi J, Yasuda S, Arai H.

Tohoku J Exp Med. 2022 Oct 25;258(3):167-175. doi: 10.1620/tjem.2022.J078. Epub 2022 Sep 15.

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials

Ostrowitzki S, Bittner T, Sink KM, Mackey H, Rabe C, Honig LS, Cassetta E, Woodward M, Boada M, van Dyck CH, Grimmer T, Selkoe DJ, Schneider A, Blondeau K, Hu N, Quartino A, Clayton D, Dolton M, Dang Y, Ostaszewski B, Sanabria-Bohórquez SM, Rabbia M, Toth B, Eichenlaub U, Smith J, Honigberg LA, Doody RS.

JAMA Neurol. 2022 Nov 1;79(11):1113-1121. doi: 10.1001/jamaneurol.2022.2909.

Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Qin M, Wu J, Zhou Q, Liang Z, Su Y.

J Psychiatr Res. 2022 Nov;155:371-379. doi: 10.1016/j.jpsychires.2022.09.039. Epub 2022 Sep 25.

Efficacy of methylphenidate for the treatment of apathy in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled studies

Lee CW, Chen JY, Ko CC, Chuang MH, Tsai WW, Sun CK, Hung KC.

Psychopharmacology (Berl). 2022 Dec;239(12):3743-3753. doi: 10.1007/s00213-022-06261-y. Epub 2022 Oct 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias